Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ FutureTech II Acquisition Corp. (FTII) Stock Forecast & Price Prediction United States | OTC | Financial Services | Shell Companies
$12.02
+0.00 (0.00%)Did FTII Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if FutureTech II is one of their latest high-conviction picks.
FTII has shown a year-to-date change of 0.0% and a 1-year change of 2.0%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for FTII. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for FTII.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to FutureTech II based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
FutureTech II Acquisition Corp. has a market capitalization of $51.57M with a P/E ratio of 230.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -330.4%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Facilitates tech companies going public.
The company operates as a special purpose acquisition company (SPAC), focusing on merging with or acquiring technology-driven enterprises. It generates revenue by facilitating the public listing of these companies, allowing them to access capital markets without the traditional IPO process.
FutureTech II Acquisition Corp. targets industries undergoing digital transformation, such as artificial intelligence and cybersecurity. By partnering with innovative tech companies, it aims to leverage their growth potential and contribute to shifts in the technology infrastructure.
FutureTech II Acquisition Corp. (NASDAQ: FTII) received a deficiency notice from Nasdaq for failing to file its Q3 10-Q on time and is at risk of delisting due to non-compliance with multiple listing rules.
FutureTech II Acquisition Corp.'s non-compliance with Nasdaq listing rules raises delisting risks, impacting stock liquidity and market perception, potentially leading to decreased investor confidence.
Longevity Biomedical and FutureTech II Acquisition Corp. have entered into a business combination agreement. The new entity will trade as Longevity Biomedical, Inc. under the ticker "LBIO" on Nasdaq.
The merger between Longevity Biomedical and FutureTech could create a new player in the biopharmaceutical space, attracting investor interest in innovative health technologies and potential growth opportunities.
Most AI stocks are viewed as speculative investments, with Microsoft and Nvidia being exceptions. Caution is advised for regular investors considering AI stocks.
The perception of AI stocks as speculative may lead to reduced investment interest, impacting stock prices and market volatility in the sector, particularly for companies outside of Microsoft and Nvidia.
Analyst forecasts for FutureTech II Acquisition Corp. (FTII) are not currently available. The stock is trading at $12.02.
Analyst ratings for FTII are not currently available. The stock is currently trading at $12.02. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for FTII are not currently available. The stock is trading at $12.02.
The company operates as a special purpose acquisition company (SPAC), focusing on merging with or acquiring technology-driven enterprises. It generates revenue by facilitating the public listing of these companies, allowing them to access capital markets without the traditional IPO process.
Price targets from Wall Street analysts for FTII are not currently available. The stock is trading at $12.02.
Price targets from Wall Street analysts for FTII are not currently available. The stock is trading at $12.02.
Analyst ratings for FTII are not currently available. The stock is trading at $12.02.
Stock price projections, including those for FutureTech II Acquisition Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.